Sort
261,768 grants matching “gene therapy”
Advancing Cancer Therapy through Ground Breaking Research in Radiation Biology
$942,807David G Kirsch · Duke University · R35 · FY2016 · CA
Advancing Cancer Therapy through Ground Breaking Research in Radiation Biology
$942,807David G Kirsch · Duke University · R35 · FY2021 · CA
Advancing Cancer Therapy through Ground Breaking Research in Radiation Biology
$942,807David G Kirsch · Duke University · R35 · FY2018 · CA
Core B: Immunoprofiling and Protective Immunity
$942,805Mandy L. Ford · Emory University · U19 · FY2017 · AI
Bay Area Cancer Target Discovery and Development
$942,785Michael T McManus · University Of California, San Francisco · U01 · FY2024 · CA
GENETIC SUSCEPTIBILITY TO CANCER IN MULTIETHNIC COHORTS
$942,733University Of Southern California · U01 · FY2000 · CA
Project 1: Differential Roles of ApoE Isoforms in Neural Network Dysfunction of Alzheimer's Disease
$942,704Yadong Huang · J. David Gladstone Institutes · P01 · FY2021 · AG
Project 1: Differential Roles of ApoE Isoforms in Neural Network Dysfunction of Alzheimer's Disease
$942,704Yadong Huang · J. David Gladstone Institutes · P01 · FY2022 · AG
Project 1: Differential Roles of ApoE Isoforms in Neural Network Dysfunction of Alzheimer's Disease
$942,704Yadong Huang · J. David Gladstone Institutes · P01 · FY2024 · AG
Project 1: Differential Roles of ApoE Isoforms in Neural Network Dysfunction of Alzheimer's Disease
$942,704Yadong Huang · J. David Gladstone Institutes · P01 · FY2023 · AG
Telomeres and Telomerase in Cancer
$942,624Carol W Greider · Johns Hopkins University · R35 · FY2019 · CA
HIV-Receptor Interactions and Related Anti-HIV Strategies
$942,587Edward Berger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Growth, Differentiation and Genetic Alteration of Human ES Cells
$942,469Gordon M Keller · Icahn School Of Medicine At Mount Sinai · P20 · FY2006 · GM
Broad spectrum therapeutics targeting resolvase enzymes
$942,460Frederic D Bushman · University Of Pennsylvania · U01 · FY2010 · AI
Optimizing the graft versus leukemia effect for pediatric ALL
$942,362Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
NCMRR-DC Core Molecular & Functional Outcome Measures in Rehabilitation Medicine
$942,321Eric P Hoffman · Children'S Research Institute · R24 · FY2011 · HD
IL-2 Family Cytokines and Receptors-- Mechanisms of Regulation & Action
$942,313Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Novel Small Molecule Therapeutic for Spinal Cord Injury
$942,288Prakash Narayan · Angion Biomedica Corporation · R44 · FY2007 · NS
Ramipril treatment of claudication: oxidative damage and muscle fibrosis
$942,286Iraklis Ilias Pipinos · University Of Nebraska Medical Center · R01 · FY2017 · AG
Genomic Diagnosis and Individualized Therapy of Highly Penetrant Genetic Diabetes
$942,207Toni I. Pollin · University Of Maryland Baltimore · U01 · FY2017 · HG
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
$942,132Pablo Tamayo · University Of California, San Diego · U01 · FY2021 · CA
Systems Biology Analysis of Influenza A Virus and Ebola Virus
$941,909Yoshihiro Kawaoka · University Of Wisconsin-Madison · U19 · FY2013 · AI
Exploiting synthetic lethality of hematopoietic lineage cells to develop novel ta
$941,894Kyle Russell Bonneau · Cellecta, Inc. · R44 · FY2011 · CA
Reducing Latent Viral Reservoirs in Infant Macaques
$941,882Nancy Logan Haigwood · Oregon Health & Science University · R01 · FY2014 · HD
S.japonicum and pregnancy outcomes: an RCT
$941,861Jennifer F Friedman · Rhode Island Hospital · U01 · FY2008 · AI